138 related articles for article (PubMed ID: 17190251)
1. [DREAM Study for prevention of diabetes. What conclusions may we draw?].
Seissler J
MMW Fortschr Med; 2006 Oct; 148(41):15. PubMed ID: 17190251
[No Abstract] [Full Text] [Related]
2. [Diabetes manifestation. Should they be prevented with drugs?].
MMW Fortschr Med; 2006 Oct; 148(41):12, 15. PubMed ID: 17190250
[No Abstract] [Full Text] [Related]
3. Diabetes prevention: still no effective drugs.
Prescrire Int; 2007 Dec; 16(92):258. PubMed ID: 18095391
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic treatment options for prediabetes.
Hsueh WA; Handelsman Y
Nat Clin Pract Endocrinol Metab; 2008 Jul; 4(7):380-1. PubMed ID: 18523427
[No Abstract] [Full Text] [Related]
5. [Glitazones and congestive heart failure: update on PROactive, ADOPT, DREAM and RECORD clinical trials].
De Flines J; Scheen AJ
Rev Med Suisse; 2007 Aug; 3(122):1876, 1878-83. PubMed ID: 17896661
[TBL] [Abstract][Full Text] [Related]
6. Prevention of diabetes: a strategic approach for individual patients.
Shin JA; Lee JH; Kim HS; Choi YH; Cho JH; Yoon KH
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():79-84. PubMed ID: 23280871
[TBL] [Abstract][Full Text] [Related]
7. [In high risk for diabetes should drugs be used for prevention? (interview by Dr. Judith Neumaier)].
Hanefeld M
MMW Fortschr Med; 2002 Oct; 144(40):12. PubMed ID: 12440285
[No Abstract] [Full Text] [Related]
8. [Primary prevention of diabetes mellitus by pharmacological intervention].
Noda M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
[No Abstract] [Full Text] [Related]
9. [Study with alpha-glucosidase inhibitor proves: diabetes can be delayed].
MMW Fortschr Med; 2002 Aug; 144(33-34):57. PubMed ID: 12380153
[No Abstract] [Full Text] [Related]
10. Primary prevention of type 2 diabetes.
Wallace C
Tenn Med; 2002 Nov; 95(11):471-2. PubMed ID: 12436864
[No Abstract] [Full Text] [Related]
11. More data needed on drug to delay the onset of diabetes.
Comeau P
CMAJ; 2006 Nov; 175(10):1192-3. PubMed ID: 17098942
[No Abstract] [Full Text] [Related]
12. Prediabetes.
Ashraf MS
J Indian Med Assoc; 2007 Jan; 105(1):10. PubMed ID: 17802968
[No Abstract] [Full Text] [Related]
13. Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.
McFarlane SI; Provilus A; Shin JJ
J Cardiometab Syndr; 2007; 2(2):149-50. PubMed ID: 17684471
[No Abstract] [Full Text] [Related]
14. [Effects of thiazolidinediones on dyslipidemia in patients with type 2 diabetes. Are all equally vasoprotective?].
Haberbosch W
Herz; 2007 Feb; 32(1):51-7. PubMed ID: 17323035
[TBL] [Abstract][Full Text] [Related]
15. Prevention of diabetes with rosiglitazone: Evidence of benefit or unexpected harm?
Stulc T; Ceska R
Med Hypotheses; 2008; 70(1):199-200. PubMed ID: 17855003
[No Abstract] [Full Text] [Related]
16. [Delaying and preventing type 2 diabetes mellitus].
Mehnert H
MMW Fortschr Med; 2003 Mar; 145(12):51-4. PubMed ID: 15106701
[TBL] [Abstract][Full Text] [Related]
17. DREAM study and its impact on India.
Mohan V
J Assoc Physicians India; 2006 Oct; 54():765-7. PubMed ID: 17214271
[No Abstract] [Full Text] [Related]
18. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
[No Abstract] [Full Text] [Related]
19. Drug evaluation: rivoglitazone, a new oral therapy for the treatment of type 2 diabetes.
Schimke K; Davis TM
Curr Opin Investig Drugs; 2007 Apr; 8(4):338-44. PubMed ID: 17458185
[TBL] [Abstract][Full Text] [Related]
20. Should we now ADOPT glitazones earlier in treatment of type 2 diabetes?
Howat I; Cleland SJ
Int J Clin Pract; 2007 Jul; 61(7):1071-3. PubMed ID: 17577291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
